Simple and complex retinal dystrophies are associated with profoundly different disease networks by Kiel, C et al.
1Scientific RepoRts | 7:41835 | DOI: 10.1038/srep41835
www.nature.com/scientificreports
Simple and complex retinal 
dystrophies are associated with 
profoundly different disease 
networks
Christina Kiel1,2, Claire Lastrucci1,2, Philip J. Luthert3 & Luis Serrano1,2,4
Retinopathies are a group of monogenetic or complex retinal diseases associated with high unmet 
medical need. Monogenic disorders are caused by rare genetic variation and usually arise early in life. 
Other diseases, such as age-related macular degeneration (AMD), develop late in life and are considered 
to be of complex origin as they develop from a combination of genetic, ageing, environmental and 
lifestyle risk factors. Here, we contrast the underlying disease networks and pathological mechanisms 
of monogenic as opposed to complex retinopathies, using AMD as an example of the latter. We show 
that, surprisingly, genes associated with the different forms of retinopathies in general do not overlap 
despite their overlapping retinal phenotypes. Further, AMD risk genes participate in multiple networks 
with interaction partners that link to different ubiquitous pathways affecting general tissue integrity 
and homeostasis. Thus AMD most likely represents an endophenotype with differing underlying 
pathogenesis in different subjects. Localising these pathomechanisms and processes within and 
across different retinal anatomical compartments provides a novel representation of AMD that may be 
extended to complex disease in general. This approach may generate improved treatment options that 
target multiple processes with the aim of restoring tissue homeostasis and maintaining vision.
Retinopathies, or retinal dystrophies (RD) are a group of diseases causing degeneration of a cell-rich layer in 
the eye, the retina1. Affected people generally experience a gradual loss of vision that may lead to blindness. 
Simple monogenic non-syndromic (M-NS) RD, such as retinitis pigmentosa (RP), congenital stationary night 
blindness, Leber’s congenital amaurosis, and rod-cone disease are caused by inherited rare germline mutations 
(Fig. 1a)2–5. The time of disease onset and progression is mainly driven by the genetic risk6 and the disease pheno-
type is restricted to the eye. Rare monogenic RD can also have a syndromic phenotype (M-S RD), predominantly 
cilia-associated, with multiple organs involved and pleiotropic effects, such as deafness, obesity, polydactyly, 
renal abnormalities, mild mental retardation, renal deficiency and metabolic disorders (e.g. in Usher and Bardet 
Biedl syndromes)7–9. In contrast, complex retinopathies (complex RD), such as age-related macular degeneration 
(AMD), have a later onset in life and are caused by a combination of age-related changes, common or rare genetic 
variations, and other risk factors such as lifestyle, smoking and gender10.
In recent years, the molecular basis of simple monogenic RD has expanded11–19. Experimental approaches 
to identify molecular components, their modulation, and arrangement into signalling cascades and interac-
tomes have been successfully performed, and the connection to the physiological function in the retina and to 
the pathology has been established for most genes20–25. Likewise, for AMD, an example of a complex form of a 
retinopathy, pathogenic mechanisms have been established for certain risk genes26. For example, they partic-
ipate in pathways with a known role in certain retinal compartments (e.g. retinal pigment epithelium (RPE) 
cells, Bruch’s membrane, extracellular matrix), such as the complement pathway and lipid metabolism10,27,28. 
Disease-causing proteins often work together, either in complexes or through participating in the same pathway. 
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Figure 1. Principal differences between simple and complex retinal dystrophies (RD) and disease-gene 
network. (a) Monogenetic non-syndromic and syndromic RDs are mainly driven by rare genetic variation. The 
disease onset can be very early, if the infant is born blind or develops severe vision loss soon after birth. Vision 
loss can also develop later in life. Complex retinopathies, such as age-related macular degeneration (AMD) have 
a later onset in life and are caused by a combination of common genetic risk factors, ageing and environmental/
lifestyle factors. Figure was prepared using images from Servier Medical Art by Servier (http://www.servier.com/
Powerpoint-image-bank), which is licensed under a Creative Commons Attribution 3.0 Unported License.  
(b) Disease/phenotype-gene network of 208 genes related to RD. Boxes represent genes and triangles diseases or 
phenotypes. Monogenic non-syndromic RD are coloured in yellow, monogenic syndromic RD are coloured in 
orange, and AMD in red. Green triangles represent diseases or phenotypes that manifest in tissues outside the eye 
(non-vision related). (c) Percentage of genes with a non-retinal phenotype for M-NS RD, M-S RD, and AMD.
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Therefore, network-based methods provide powerful approaches to achieve comprehensive understanding of 
the molecular basis underlying the disease and to investigate how the impact of genetic defects propagates across 
the network29,30. For example, biomarkers as readout of network perturbations can serve for disease classification 
and patient stratification. The identification of disease pathways may also illuminate new targets for drug devel-
opment. Indeed, the knowledge of molecular disease mechanisms has been the basis for therapeutic approaches 
employing gene therapy in the eye31,32, retinal generation33, use of inhibitors34,35 or small molecules affecting 
metabolism36, and splice-switching oligonucleotides37,38.
In the present study, we contrast disease networks of genes associated with simple and complex forms of 
retinal dystrophies, using AMD as an example of the latter. By taking a network-centric approach, we show that 
the different types of retinal disorders are related to fundamentally different network properties. AMD proteins 
are associated with fragmented disease networks that link to multiple generic cell pathways. For many of them 
the physiological role with respect to vision- or ageing-related functions cannot be predicted based on the net-
work analysis alone. We further observe differences with respect to the types of associated processes: while 66% 
of the genes implicated in monogenic and simple forms of the disease affect specific retinal cellular functions 
directly involved in vision (e.g. phototransduction, retinal recycling), only 7% of AMD risk genes are predicted 
to directly affect vision-related processes, but rather tend to affect tissue homeostasis processes (e.g. extracellular 
matrix remodelling, oxidative stress, inflammatory processes). Many of them are expected to play a role also in 
non-retinal tissues, consistent with their expression in many tissues, and possibly explaining the strong associa-
tion of AMD genes to non-retinal syndromic phenotypes. Interestingly, some of the tissue homeostasis processes 
are also affected because of normal ageing-induced changes in tissue anatomy and physiology. We constructed 
an initial integrated network of processes within and across retinal compartments and their modulation through 
age-related changes in retinal anatomy and physiology, risk genes and their link to pathways, and via associations 
to environmental and lifestyle factors. This anatomical disease landscape for the first time demonstrates and 
visualizes the complexity of AMD pathogenesis. In future, the knowledge may guide improved and additional 
treatment options.
Results
Contrasting simple and complex retinopathies using a network-centric approach. To con-
trast simple and complex retinopathies, we first used a classical gene- and network-centric molecular medicine 
approach, where the disease phenotype is considered as a consequence of perturbations of complex intra- and 
intercellular networks (e.g. disease-gene networks, protein-protein interaction networks, signalling/metabolic/
and transcriptional networks; see Supplementary Fig. S1). Different genetic defects can result in similar disease 
phenotypes, indicating that diseases are interconnected (‘disease-gene network’ or ‘diseasome’)29,39. To establish the 
retinal diseasome we searched the literature and databases for genes linked to retinopathies and identified a total 
of 208 genes1,10,27,28,40 and the online mendelian inheritance in man (OMIM) database) (Supplementary Table S1). 
96 genes are related to M-NS RD, 37 to M-S RD, and 90 genes are linked to AMD. For the union of 208 genes, the 
information for both retina-associated diseases and for all other (non-retinal phenotype) diseases was retrieved 
from the OMIM database and the respective disease-gene associations were depicted in a network (Fig. 1b). In 
this representation squared boxes represent genes and triangles represent diseases or phenotypes. The retinal 
diseasome discloses two remarkable features. First, there is a striking difference between the three retinal dis-
ease classes with respect to the number of genes that are additionally linked to a non-retinal phenotype. M-NS 
RDs, except for four genes, are not associated to a non-retinal tissue disease of the human body (Fig. 1c). As 
expected, a high number of non-retinal disease phenotypes are associated to genes causing M-S RD – likely 
because ciliary dysfunctions tend to affect multiple tissues and organs. The highest number of non-retinal 
associated phenotypes, however, is observed for AMD risk genes, affecting for example the kidney, skin, coronary 
arteries, and heart, or having neural or metabolic symptoms, or causing diabetes (see Supplementary Fig. S2). 
This substantiates that AMD is best considered a systemic disease. Second, the overlap of genes that are associated 
with both simple (M-NS and M-S) and complex retinopathies (AMD) is small. This suggests that the three disease 
classes influence distinct vision-related processes and functions in the retina.
As genotype-phenotype relations often arise from a higher underlying complexity, the global analysis of 
interaction networks permits the understanding of the disease mechanism on a systems-network level30,39. 
We therefore asked if simple and complex retinal disorders are associated with different protein-protein inter-
action network topologies. To reconstruct networks among the risk genes, we used the HIPPIE integrated 
protein-protein interaction database (http://cbdm.mdc-berlin.de/tools/hippie), and retrieved interactions among 
the disease proteins and among the first layer of interacting proteins (Fig. 2a; Supplementary Table S2). For M-NS 
dystrophies the resulting network is well connected. In contrast, for complex retinopathies the derived network 
is fragmented with many AMD proteins acting as ‘hubs’ for a large number of interacting partners (high ‘degree’ 
for some nodes, see Supplementary Fig. S3). Accordingly, the AMD network has a 5.4-fold lower average clus-
tering coefficient, indicating that proteins in the network link up with each other only to a limited degree (see 
Supplementary Fig. S4) and that they tend to have fewer shared neighbours (see Supplementary Fig. S5).
The high number of interaction partners for some nodes in the AMD network suggests that the same protein 
can link out to many different pathways. To analyse this, we extracted information from the HPD integrated data-
base for human pathways41 (Supplementary Table S3). Many of the AMD proteins indeed participate in multiple 
signalling and metabolic pathways (Fig. 2b; see Supplementary Fig. S6). Further, many proteins belong to general 
cell signalling pathways (e.g. ERK, TGFb, TRAIL, STAT, JNK, HIF, PI3K), suggesting that they play a role in 
numerous processes, possibly also contributing to non-retinal tissue homeostasis. To support this hypothesis, we 
analysed the enrichment of proteins of the three RD classes for gene ontology (GO) processes using g:Profiler42,43 
(see Supplementary Figs S7–S9). AMD genes are indeed not strongly enriched in GO processes (the average 
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enrichment for GO processes follows the order of NS-RD > S-RD > AMD). Altogether, the AMD network and 
pathway properties corroborate the systemic and complex disease pathogenesis.
Comparing processes affected in simple and complex retinal dystrophies. Based on the g:Profiler 
database and manual annotations using available literature, the 208 RD proteins were assigned to one (main) 
process and each process associated to a cell type or tissue compartment where this function is likely to play a role 
(‘protein-process networks’, Fig. 3a, Supplementary Table S1). In the resulting network representation, processes 
important for retinal physiology are organized hierarchically with six main classes. The first class is visual home-
ostasis with processes such as phototransduction, ciliary trafficking, neurotransmission, phagocytosis of outer 
segment disks, retinal development, and the visual retinal (Vitamin A) cycle. Indeed, most of the M-NS and M-S 
RD proteins link to these retina-specific processes (indicated as light blue hexagons in Fig. 3a). The remaining 
classes important for retinal physiology are tissue integrity (extracellular matrix turnover, angiogenesis, transep-
ithelial transport, and apoptosis), DNA and protein homeostasis, the innate immune system (inflammatory and 
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Figure 2. Protein interaction networks and pathways associated to retinal dystrophies. (a) Global protein 
interaction networks centred on RD gene products. Integrative literature based ‘omics’ protein-protein 
interaction networks for monogenic non-syndromic (M-NS), monogenic syndromic (M-S), and AMD-related 
disease gene products. The networks were retrieved from the HIPPIE database (http://cbdm.mdc-berlin.de/
tools/hippie) and displayed using Cytoscape. (b) Association of proteins to different pathways based on the 
HPD database. Network representation of between the 208 RD proteins (round rectangles) and the number 
pathways a particular protein participates (black hexagons with white number inside indicating the number 
of pathways). The size of the hexagons correlates with the number of pathways a protein is associated to (see 
legend).
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complement system processes), oxidative stress processes, metabolism, and a class with unknown proteins and 
those related to general signalling processes. These processes are expected to be important for retinal physiology, 
but at the same time they largely play a role in all (or most) human tissues (indicated as light yellow hexagons in 
Fig. 3a). The functional overlap of AMD-related genes with those of rare and simple RD is small and mainly con-
cerns extracellular matrix turnover, splicing/gene expression and protein homeostasis. Overall, we observe that 
monogenic forms of RD are predominantly associated with retina-specific processes. Indeed, a few disease mod-
ules and pathways contain most of the disease-associated genes – supporting the validity of a network-centric 
approach. In contrast, AMD proteins are highly linked to processes that likely play a role in homeostasis in 
all tissues (Fig. 3b). The fact that AMD proteins are related to – presumably – general cell functions, such as 
general signalling, cytoskeleton, chaperones, Golgi function and apoptosis is in line with the fact that AMD 
genes are in general expressed at lower levels in both, neural retina and RPE/choroid44 (Supplementary Table S1; 
see Supplementary Fig. S10). However, some AMD genes are quite highly expressed in RPE/choroid44 (see 
Supplementary Fig. S10), which is consistent with the role of some AMD genes in the complement pathway, 
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Figure 3. Functional classification of 208 RD genes and association to cell types or tissue compartments 
where this function contributes to vision-related tasks or to keeping the tissue integrity. (a) Boxes represent 
the 208 RD genes, which are coloured according to their RD disease classification. Genes are boxed according 
to their functional classification and assigned to either the retinal cell type where this process plays a role, or to 
functions affecting other retinal compartments and retinal tissue development and integrity, or to presumably 
cell general functions. (b) Statistic of proteins in the different disease classes and their association to retina-
specific and cell and tissue general functions.
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extracellular matrix remodelling, and lipid metabolism. However, many AMD gene products participate in gen-
eral pathways and signalling modules that – presumably – control a multitude of cellular functions.
An anatomy- and physiology-centric approach to understand complex and ageing-related 
retinopathies. There are two issues concerning the use of a classical molecular medicine approach to under-
stand complex diseases such as AMD. First, as discussed above, many proteins associated to AMD are involved 
in ubiquitous pathways and it is not clear which networks, if any, are specifically important for vision-related 
functions. Second, a classical molecular medicine approach misses the contributions of normal ageing processes 
and the environment and lifestyle to the pathology. There are several examples of changes in retinal anatomy and 
physiology during normal ageing. For example, quantitative and linear changes have been reported for the choroi-
dal capillary diameter (decreasing with age), Bruch’s membrane thickness (increases with age), and the capillary 
density (decrease with age)45 (Supplementary Table S4). All of this can affect the transport of nutrients, metab-
olites, waste products, etc. between compartments. Other ageing related changes affect the extracellular matrix 
turnover46 or the transition to a pro-inflammatory state during ageing47. Thus, in order to tackle complex diseases, 
a gene-/network- and pathway-centric (interactome) approach will not immediately take us to the physiologically 
relevant functions to allow understanding of disease and the identification of critical therapeutic targets. Likewise, 
simply focusing on the (patho)physiology provides only limited information for components and molecular net-
works underlying the pathology – especially if as in the case of AMD genes there only limited retina-specific 
expression. Therefore, we set out an alternative approach to understand complex and ageing-related diseases: an 
anatomy and physiology-centric molecular medicine approach (Fig. 4a). Here, we consider disease directly as a 
consequence of perturbations of tissue homeostasis. Tissue homeostasis in turn is best represented on the level of 
processes that can be modulated, e.g. by normal ageing or through disease associated proteins and pathways that 
link to those processes, but also through processes that affect each other within and across compartments (‘pro-
cess networks’). We first performed a detailed literature analysis of all processes important in the different retinal 
compartments together with their interdependencies (Supplementary Table S4; see examples in Fig. 4b). We also 
indicated which processes are modulated through normal ageing and by environmental factors (e.g. UV light). 
Finally, a specific manual literature analysis was performed to find connections between processes and pathways 
(including cell general signalling pathways). If a link of a process to a pathway has been described previously in 
the literature, a connection to the respective disease protein was added via the respective pathway(s). Indeed, 
some of the cell general pathways could be linked to processes that have been shown previously to play a role for 
retinal functions (e.g. Bruchs’ membrane thickness and p38 pathway, melanin production in RPE cell and PKA 
pathway, collagen production in the extracellular matrix and the PI3K/Akt pathway).
The resulting (patho)physiological process map highlights many inter-dependencies, e.g. between the photo-
receptor and the RPE (interdependencies of their energy metabolism) and between the RPE and Bruch’s mem-
brane (epithelial transport of nutrients and waste products) (Fig. 4b). The process map also features that many 
dysregulated functions affect RPE cells, which thus stick out to be the critical cell type regulating retinal tissue 
cohesion. We also recognize innate immunity and inflammation processes turning up in several retinal compart-
ments. Taken together, our AMD process network together with the different types of modulators represents an 
initial graphical representation of this disease, which can be refined over the coming years.
Discussion
We have shown here that different forms of retinal dystrophies (monogenic or complex) are associated with fun-
damentally different disease networks. In particular, AMD risk genes participate in fragmented protein interac-
tion networks with many interaction partners that are not connected. For those genes the associated cellular and 
physiological functions with respect to vision loss cannot be directly predicted based on the integration with pub-
lished interaction networks. Further, it is likely that multiple pathways are affected, each through common genetic 
variation or general ageing processes that affect tissue physiology and predispose to disease manifestation at some 
point in life. Our integrated systems-level analysis shows that AMD pathogenesis likely manifests because of the 
deregulation of several cellular and tissue processes, suggesting that there are different forms of AMD with shared 
intermediate pathophenotypes (endophenotypes)48. We show that for complex diseases a gene-/network- and 
pathway-centric (interactome) approach does not guide the way to the physiologically distinct functions directly 
relevant to vision. To go beyond these limitations we propose to bridge information derived from physiology and 
interactomics and place tissue processes centre stage. In the future, integrating and connecting these processes 
within retinal cell and compartment states may also facilitate the generation of multiscale agent-based models49 of 
AMD pathogenesis. These models may serve as the cornerstone for integrative risk prediction models for patients.
The objective of classical molecular medicine is to understand the pathways and protein-protein interactions 
that link genes to changes in cellular functions and to elucidate how disease mutations affect protein activities, 
levels and network, with the final aim to identify targets for intervention. This network-centric view is probably 
biased by diseases such as cancer or monogenic diseases, which manifest rather on alterations of cellular pro-
cesses, in the first place. The concept of protein-protein interactions, networks, and pathways is excellent for such 
‘cellular diseases’, and enables therapeutic approaches that seek to inhibit protein interactions, inhibit protein 
activities, restore the folding of a protein, or express a non-functional protein through gene therapy. In order to 
tackle complex and ageing-related diseases such as AMD (similar concepts will also apply to arthritis, diabetes, 
and Alzheimer’s disease etc.), a pure cell network-centric approach may not be effective, as often tissue processes 
and tissue homeostasis is affected. First, because of the bias in studying networks in cells, we only have sparse 
information on networks across cells and tissues (exceptions are cell adhesion interactions50. Second, many of the 
ageing-related changes, rather than affecting interactions in tissues, affect the tissues physiology, integrity, and 
homeostasis. In our view, this known knowledge on pathological changes in retinal tissue homeostasis and pro-
cesses should be the starting point to generate phenotypic descriptions of cells and compartments during AMD 
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Figure 4. Anatomy- and physiology-centric approach to understand complex and ageing-related 
retinopathies and (patho)physiological process networks. (a) Schematic view summarizing the anatomy- 
and physiology-centric approach to molecular medicine where networks of processes are used to describe the 
anatomy and physiology, their interdependencies and modulation. (b) Selection of processes describing the 
tissue physiology in different retinal compartments and how they affect each other (see Supplementary Table S4 
for a more complete list). On the left side the normal physiological process networks are shown and on the right 
side the pathological process networks together with their modulators (see symbols used in (a)).
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disease progression (processes and states). A critical task will be to find ways to integrate the physiology with 
‘omics’ data – some approaches towards this goal are already taken within the ‘VPH/Physiome Project’ (http://
www.vph-institute.org/; http://physiomeproject.org/), an effort towards a complete virtual description of human 
physiology that includes molecular details.
Understanding processes and tissue physiology may also have advantages compared to classical protein/net-
work centric approaches and pave the way for improved and new therapeutic avenues. In fact, the beneficial 
effects of antioxidants already perfectly align with a process-based approach to therapy51–53. Exploring this fur-
ther, other processes to be targeted for therapy could be tissue metabolism, i.e. affecting the interplay of lipid 
and glucose metabolic branches54. Likewise, targeting the complement system in retinal inflammatory diseases 
will require the comprehension of processes rather than individual protein-protein interactions55. In contrast, 
treatment of the later form of AMD using vascular endothelial growth factor (VEGF) inhibitors can be rather 
considered a classical gene/network-based therapy approach56. These inhibitors target a specific pathway respon-
sible for stimulating growth of abnormal blood vessels in the retina. While they considerably slow down disease 
progression and may prevent vision loss for some time, they do not provide a real cure as retinal atrophy at later 
stages nevertheless occurs. Thus, treatments targeted towards tissue homeostasis may be an alternative and pos-
sibly superior approach compared to drugs that target directly interactions mediated by the disease gene – the 
common approach in current molecular medicine approaches taken for example in cancer. These interventions 
could be personalized by addressing one or more specific processes, depending on the patient’s genetic profile.
Methods
Disease-gene networks. The list of genes with established genetic associations to M-NS RD and M-S RD 
was based on databases (the online mendelian inheritance in man (OMIM) database, GeneReviews® (http://
www.ncbi.nlm.nih.gov/books/NBK1417/)40, and a recent review article1. Genes associated to AMD were retrieved 
from the union of genes reported in several publication10,27,28,57 (Supplementary Table S5). Non-retinal pheno-
types were extracted from the OMIM database and classified through manual literature searches according to 
the type of disease (Metabolism, Immune System, Diabetes, Developmental, Cancer) or the organ where they 
predominantly manifest (Coronary artery, Kidney, Blood system, Neuronal, Heart, Skin). The diseasome linking 
genes with phenotypes was represented using Cytoscape.
Protein-protein interaction networks. The HIPPIE integrated protein-protein interaction database 
(http://cbdm.mdc-berlin.de/tools/hippie) was used to extract PPI information for risk gene products and their 
first layer of interacting proteins separately for the three disease classes (Supplementary Table S2). The networks 
were represented in cytoscape and the topological properties were analysed using the Cytoscape ‘Network 
Analysis’ plugin.
Functional annotations. Functional annotations were retrieved through manual literature searches and 
using g:Profiler selecting ‘Biological Process’ as Gene Ontology (http://biit.cs.ut.ee/gprofiler/). If a gene is linked 
to more than one group it was assigned to the function/process that is more relevant to the known retinal biol-
ogy function. For example, if a gene is linked to both cell cycle and cilia function, the ciliary function group was 
selected.
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